Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu

Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu

0.5 mg
€100,00

Sie können eine Angebotsanfrage erstellen, nachdem Sie das Produkt in den Warenkorb gelegt haben.

Zu Produktinformationen springen
Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
  • Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
  • Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu

Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu

Produkt-ID: 3403

Myristoyl- Ser- Ile- Tyr- Arg- Arg- Gly- Ala- Arg- Arg- Trp- Arg- Lys- Leu (Trifluoroacetate Form)

€100,00
exkl. 19% MwSt.
Beschreibung

Myristoyl-PKC ζ (113-125)/ζ-Pseudosubstrate Inhibitory Peptide (ZIP)

M.W. 1928.40

C90H154N30O17

Myristoyl- Ser- Ile- Tyr- Arg- Arg- Gly- Ala- Arg- Arg- Trp- Arg- Lys- Leu (Trifluoroacetate Form)

Myristoylated Cell Permeable PKCζ Pseudosubstrate Inhibitor

Synthetic Product

The purity is guaranteed to be higher than 99% by HPLC

Referenzen:

1. C. Laudanna, D. Mochly-Rosen, T. Liron, G. Constantin and E.C. Butcher, J. Biol. Chem., 273, 30306 (1998) (Pharmacol.) 2. S. Lim, J.W. Choi, H.S. Kim, Y.-H. Kim, K. Yea, K. Heo, J.H. Kim, S.-H. Kim, M. Song, J.I. Kim, S.H. Ryu and P.-G. Suh, Life Sci., 82, 733 (2008) (Biochem.) 3. T. Hirose, D. Satoh, H. Kurihara, C. Kusaka, H. Hirose, K. Akimoto, T. Matsusaka, I. Ichikawa, T. Noda and S. Ohno, PLoS ONE, 4, e4194 (2009) (Pharmacol. & Histochem.) 4. P.V. Migues, O. Hardt, D.C. Wu, K. Gamache, T.C. Sacktor, Y.T. Wang and K. Nader, Nat. Neurosci., 13, 630 (2010) (Pharmacol.)

You may also like